New stepwise ablation method may reduce esophageal injury in AF patients
NCT ID NCT07354737
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a voltage-guided stepwise ablation strategy against the standard circumferential approach for treating atrial fibrillation. 130 adults with AF undergoing their first catheter ablation were randomly assigned to one of the two methods. The goal was to see if the stepwise technique could achieve similar heart rhythm control while potentially causing fewer esophageal injuries.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Radiofrequency ablation catheter system
What this could lead to
If successful, this approach could reduce the risk of esophageal injury during atrial fibrillation ablation while still effectively controlling the heart rhythm.
What could go wrong
This is a completed trial with 130 participants, so results are limited in size. The stepwise method may not be as effective as standard ablation for preventing arrhythmia recurrence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ajou University Hospital
Suwon, Gyeonggi-do, 16499, South Korea